Linda Shapiro Manning - 09 Feb 2022 Form 4 Insider Report for RHYTHM PHARMACEUTICALS, INC. (RYTM)

Role
Chief Medical Officer
Signature
/s/ Hunter Smith, Attorney-in-Fact for Linda Shapiro Manning
Issuer symbol
RYTM
Transactions as of
09 Feb 2022
Net transactions value
$0
Form type
4
Filing time
11 Feb 2022, 20:34:18 UTC
Previous filing
15 Sep 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RYTM Stock Option (Right to Buy) Award $0 +75,000 $0.000000 75,000 09 Feb 2022 Common Stock 75,000 $6.80 Direct F1
transaction RYTM Restricted Stock Units Award $0 +12,500 $0.000000 12,500 09 Feb 2022 Common Stock 12,500 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock options were granted on February 9, 2022. The options vest and become exercisable in 16 substantially equal installments upon the Reporting Person's completion of each three full months of successive service to the Issuer following the grant date.
F2 Each restricted stock unit represents a contingent right to receive one share of Issuer common stock.
F3 The restricted stock units vest as to 25% of the total shares on each of February 9, 2023, February 9, 2024, February 9, 2025 and February 9, 2026. The restricted stock units have no expiration date.